XML 77 R62.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment reporting (Details)
$ in Millions
3 Months Ended
Nov. 30, 2017
USD ($)
segment
Nov. 30, 2016
USD ($)
Segment Reporting Information [Line Items]    
Number of reportable segments | segment 3  
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales $ 30,740 $ 28,501
Adjusted operating income 1,809 1,726
Adjustments to equity earnings in AmerisourceBergen (189) (41)
Acquisition-related amortization (85) (82)
Hurricane-related costs (83)  
LIFO provision (54) (58)
Acquisition-related costs (51) (17)
Legal settlement (25)  
Cost transformation   (81)
Operating income 1,322 1,447
Retail Pharmacy USA    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales 22,489 20,659
Adjusted operating income 1,377 1,289
Retail Pharmacy International    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales 3,083 2,962
Adjusted operating income 210 213
Pharmaceutical Wholesale    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales 5,168 4,880
Adjusted operating income 224 224
Reportable Segments    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales 30,740 28,501
Reportable Segments | Retail Pharmacy USA    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales 22,489 20,659
Adjusted operating income 1,377 1,289
Reportable Segments | Retail Pharmacy International    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales 3,083 2,962
Adjusted operating income 210 213
Reportable Segments | Pharmaceutical Wholesale    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales 5,718 5,417
Adjusted operating income 224 224
Eliminations    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales (550) (537)
Adjusted operating income (2) 0
Eliminations | Retail Pharmacy USA    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales 0 0
Eliminations | Retail Pharmacy International    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales 0 0
Eliminations | Pharmaceutical Wholesale    
Segment Reporting Information, Operating Income (Loss) [Abstract]    
Sales $ 550 $ 537